| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/21/2006 | WO2006099165A1 Crystalline forms of a biphenyl compound |
| 09/21/2006 | WO2006099132A1 Azacytosine analogs and derivatives |
| 09/21/2006 | WO2006099121A2 Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof |
| 09/21/2006 | WO2006099091A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099075A2 Certain substituted amides, method of making, and method of use thereof |
| 09/21/2006 | WO2006099058A2 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
| 09/21/2006 | WO2006099032A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099031A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099015A2 Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders |
| 09/21/2006 | WO2006098999A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006098997A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006098979A2 Aminopterin dosage forms and methods for inflammatory disorders |
| 09/21/2006 | WO2006098969A2 Quinazolinone t-type calcium channel antagonists |
| 09/21/2006 | WO2006098962A1 Compounds for inhibiting ksp kinesin activity |
| 09/21/2006 | WO2006098961A2 Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity |
| 09/21/2006 | WO2006098918A2 Substituted gamma lactams as therapeutic agents |
| 09/21/2006 | WO2006098912A1 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 09/21/2006 | WO2006098852A2 Hydroxyalkyl substituted imidazoquinolines |
| 09/21/2006 | WO2006098834A2 Crystalline forms of ziprasidone mesylate |
| 09/21/2006 | WO2006098767A2 Treatment of adhd |
| 09/21/2006 | WO2006098761A2 Hsp90 inhibitors, methods of making and uses therefor |
| 09/21/2006 | WO2006098699A1 Glycolipids of branched chain alkyl oligosaccharides for liquid crystal and related applications |
| 09/21/2006 | WO2006098684A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase. |
| 09/21/2006 | WO2006098683A1 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 09/21/2006 | WO2006098628A1 Oral dosage forms of gemcitabine derivatives |
| 09/21/2006 | WO2006098624A2 Anti-viral use of a coumarin agent |
| 09/21/2006 | WO2006098620A1 Use of derivatives comprising a coumarin group for the preparation of an antiviral agent, derivatives comprising a coumarin group, a method for the preparation thereof, and pharmaceutical compositions containing them |
| 09/21/2006 | WO2006098607A1 Histamine-containing composition for the treatment of allergic diseases |
| 09/21/2006 | WO2006098604A1 Pharmaceutical composition for preventing and treating diabetes or glucose control abnormality comprising ginsenosides |
| 09/21/2006 | WO2006098603A2 Composition comprising isoorientin for suppressing histamine |
| 09/21/2006 | WO2006098524A1 Prophylactic/therapeutic agent for stress-induced bowel disease |
| 09/21/2006 | WO2006098519A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 09/21/2006 | WO2006098496A1 Coordination compound composed of diaminocyclohexane platinum (ii) and block copolymer and anti-cancer agent comprising the same |
| 09/21/2006 | WO2006098394A1 Method for inhibiting lipid absorption and lipid absorption inhibitor |
| 09/21/2006 | WO2006098371A1 Therapeutic agent and prophylactic agent for endometriosis and adenomyosis uteri |
| 09/21/2006 | WO2006098355A1 Anticancer compound, intermediate therefor, and processes for producing these |
| 09/21/2006 | WO2006098353A1 External preparation |
| 09/21/2006 | WO2006098342A1 Piperazinyl compounds |
| 09/21/2006 | WO2006098332A1 Promoter for hard tissue formation |
| 09/21/2006 | WO2006098314A1 Novel sugar uptake activator and method for screening the same |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | WO2006098304A1 Novel secretory protein derived from pituitary cell and use of the same |
| 09/21/2006 | WO2006098292A1 Therapeutic agent for ophthalmic disease |
| 09/21/2006 | WO2006098241A1 Pharmaceutical composition containing hardly water soluble medicament |
| 09/21/2006 | WO2006098154A1 Hair growth tonic |
| 09/21/2006 | WO2006098074A1 Apoptosis inducing agent for prostate carcinoma cell |
| 09/21/2006 | WO2006097970A1 Use of inhibitors of steroid (testosterone) activity (i. a. estrogens) or antiandrogens) for treatment of substance correlated disorders like drug abuse |
| 09/21/2006 | WO2006097946A1 Topiramate tablet formulation |
| 09/21/2006 | WO2006097943A2 Pharmaceutical compositions of amlodipine and benazepril |
| 09/21/2006 | WO2006097938A1 Stable liquid suspension formulation comprising tibolone and process for producing the same |
| 09/21/2006 | WO2006097849A1 9a-carbamoyl and thiocarbamoyl azalides with anti-inflammatory activity |
| 09/21/2006 | WO2006097848A1 Hiv-1 virion maturation inhibitors, compositions and treatments using the same |
| 09/21/2006 | WO2006097817A1 N- (n-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain |
| 09/21/2006 | WO2006097809A2 Novel tyrosine derivatives |
| 09/21/2006 | WO2006097808A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 09/21/2006 | WO2006097793A2 Compositions capable of facilitating penetration across a biological barrier |
| 09/21/2006 | WO2006097768A2 Treatment of intestinal conditions by a compound which causes rna interference |
| 09/21/2006 | WO2006097766A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 09/21/2006 | WO2006097730A1 Analogues of the azinomycins as anti-tumour agents and as prodrugs |
| 09/21/2006 | WO2006097691A1 Fused thiazole derivatives having affinity for the histamine h3 receptor |
| 09/21/2006 | WO2006097628A1 Composition based on an avermectin and azelaic acid in particular for treating rosacea |
| 09/21/2006 | WO2006097625A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/21/2006 | WO2006097624A1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof |
| 09/21/2006 | WO2006097605A1 Pharmaceutical compositions containing a combination of a cannabinoid receptor antagonist compound and an antipsychotic agent |
| 09/21/2006 | WO2006097588A1 Use of compounds derived from pyrimidinetrione as acetyl cholinesterase inhibitors, compositions containing said derivatives, and the uses thereof |
| 09/21/2006 | WO2006097570A1 A combination treatment for enhancing diuresis |
| 09/21/2006 | WO2006097547A1 Use of 5'-methylthioadenosine (mta) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection |
| 09/21/2006 | WO2006097534A1 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication |
| 09/21/2006 | WO2006097527A1 Use of acetyl-leucine for preparing a drug for treating balance disorders |
| 09/21/2006 | WO2006097474A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | WO2006097472A2 Novel inhibitors of glutathione-s-transferase |
| 09/21/2006 | WO2006097460A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | WO2006097459A1 Method for preventing cardiovascular diseases |
| 09/21/2006 | WO2006097458A1 Novel combination |
| 09/21/2006 | WO2006097456A1 Taste masked dosage form containing roflumilast |
| 09/21/2006 | WO2006097449A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 09/21/2006 | WO2006097447A1 Combined use of herbal cigarettes and nicotine replacement therapy |
| 09/21/2006 | WO2006097441A1 Potassium channel modulating agents and their medical use |
| 09/21/2006 | WO2006097391A1 Use of 2 -anilino - 3 , 4 -dihydro - quinazolines as 5ht5a receptor antagonists |
| 09/21/2006 | WO2006097361A1 Sublingual coated tablet |
| 09/21/2006 | WO2006097344A1 Pharmaceutical tablets of crystalline type ii aripiprazole |
| 09/21/2006 | WO2006097340A1 1,7-naphthyridines as pde4 inhibitors |
| 09/21/2006 | WO2006097337A2 11β-HYDROXYSTEROID DEHYDROGENASES |
| 09/21/2006 | WO2006097323A1 TETRAHYDRO-ISOQUINOLIN-l-ONES FOR THE TREATMENT OF CANCER |
| 09/21/2006 | WO2006097293A2 Combination of a steroid sulfatase inhibitor and an ascomycin |
| 09/21/2006 | WO2006097292A1 Anti-inflammatory compounds |
| 09/21/2006 | WO2006097283A1 Use of angelic acid esters as an antiphlogistic active ingredient and antiphlogistic preparations |
| 09/21/2006 | WO2006097273A1 Compounds having immunomodulator activity |
| 09/21/2006 | WO2006097270A1 Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors |
| 09/21/2006 | WO2006097267A1 Vitamin mixtures |
| 09/21/2006 | WO2006097262A1 Semi-synthetic taxane derivatives with antitumor activity |
| 09/21/2006 | WO2006097261A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/21/2006 | WO2006097260A1 Adenosine derivatives having a2a receptor activity |
| 09/21/2006 | WO2006097258A1 The use of n-butylbenzenesulphonamide as an antimicrobial agent |
| 09/21/2006 | WO2006097250A1 The combination of anticholinergics and leukotriene recptor antagonists for the treatment of repiratory diseases |
| 09/21/2006 | WO2006097247A1 The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis |
| 09/21/2006 | WO2006097220A1 Pyrimidine carboxylic acid derivatives and use thereof |
| 09/21/2006 | WO2006097176A1 Phthalazinones |
| 09/21/2006 | WO2006097169A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 09/21/2006 | WO2006097122A1 Ferrous fructose-1,6-diphosphate, use, composition and process for the obtainment thereof |